AxoGen (AXGN) EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -23.5 | -23.5 | -13.3 | 6.08 | 0.192 | 5.69 | |
| Changes by years, y/y, % | 0% | -43% | -146% | -97% | ||||
AxoGen. EBITDA US GAAP, bln rub
AxoGen. EBITDA US GAAP, changes, %
AxoGen. EBITDA US GAAP, sum by quarters, bln rub
AxoGen (AXGN) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 0.298 | 4.38 | 12.6 | -8.50 | -2.83 | 5.69 | |
| Changes by years, y/y, % | -112% | +88% | +532% | -304% | -1 050% | |||
| Changes by quarters, q/q, % | -93% | +1 368% | +189% | -167% | -67% | |||